Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.3 USD | -0.60% | +8.20% | +2.48% |
05-14 | Earnings Flash (OVID) OVID THERAPEUTICS Posts Q1 Revenue $148,000 | MT |
05-14 | Ovid Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.48% | 236M | |
+7.75% | 113B | |
+10.36% | 106B | |
+0.41% | 22.27B | |
-11.97% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.39% | 17.24B | |
+7.02% | 14.29B | |
+36.26% | 12.52B |
- Stock Market
- Equities
- OVID Stock
- News Ovid Therapeutics Inc.
- Ovid Therapeutics : Cantor Fitzgerald Downgrades Ovid Therapeutics to Neutral from Overweight, Adjusts PT to $4 from $8